Lava Therapeutics

Description: Lava Therapeutics develops bispecific antibodies to engage gamma-delta T cells for treating hematological & solid cancers.

Country: Netherlands

Based in: Utrecht

Founded: 2016

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Life Science', 'Medical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.